Testing a new imaging tracer for vulvar cancer
Part of Cancer clinical trials.
This study is testing whether a special imaging tracer called [18F]F-FAPI-74 can be used to see vulvar cancer cells. It uses stored tissue samples from previous surgeries to see if the tracer binds to the cancer cells, which might lead to better imaging in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with invasive vulvar cancer, specifically the squamous cell type.
- Your doctor has stored tissue samples from your primary tumor or from lymph nodes where the cancer spread.
- These samples are stored in a special way (like FFPE or OCT) and there is enough left for this study.
- You do not have any other type of cancer besides vulvar cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
This study tests a new kind of PET/CT scan that uses a tracer called 18F-FAPI to see if it can better detect cancer in the lymph nodes under the arm after you've already had chemotherapy or targeted therapy before surgery. If successful, this could help doctors plan more precise surgery and avoid removing unnecessary lymph nodes.
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This study tests a new imaging method that combines a special PET scan (FAPI) with MRI to see if it can better find hidden invasive cancer in people with large areas of ductal carcinoma in situ (DCIS). It aims to improve surgical planning and avoid second surgeries.
This study uses a new imaging agent called [68Ga]-FAPI-JNU to take detailed pictures of tumors with a PET/CT scan. It aims to see how well this tracer works in people with various types of cancer.
Hear when a new Vulvar Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.